Friday, March 06, 2009 10:56:37 AM
I don't know if you guys are in this play and I'm not trying to pump the stock but take a look at LVWR (.095) their has been massive insider buying and change of board directors. This could be a buyout opportunity for some. I also noticed that they have put no press release as to the message they recieved with the delisting of the stock sent to them by NASDAQ. Which IMO means they are working on something with another company if they didn't let shareholders know if they are going to appeal it or not. If this message gets deleted I understand.
Recent XTLB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/22/2026 08:11:21 PM
- XTL Announces Receipt of Staff Delist Determination from Nasdaq • GlobeNewswire Inc. • 05/22/2026 08:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2026 09:09:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/07/2026 12:10:18 PM
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 04/30/2026 08:34:40 PM
- Washington Just Opened the Door to Psychedelic Medicine; This Microcap Already Has a Key • AllPennyStocks.com • 04/29/2026 08:21:50 PM
- XTL Biopharmaceuticals (XTLB) acquisition of Psyga Bio targets psychedelic biotech growth • IH Market News • 04/29/2026 02:47:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2026 01:07:41 PM
- XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies • GlobeNewswire Inc. • 04/29/2026 12:58:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:01:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/20/2026 08:11:31 PM
- XTL Biopharmaceuticals Announces ADS Ratio Change • GlobeNewswire Inc. • 03/20/2026 08:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/10/2026 08:05:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/27/2026 09:34:26 PM
- XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing • GlobeNewswire Inc. • 02/27/2026 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/24/2026 09:05:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2026 09:05:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/17/2026 09:05:16 PM
- XTL Update on Recent Developments • GlobeNewswire Inc. • 01/29/2026 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/28/2026 01:58:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2026 09:15:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2026 09:15:09 PM
- XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency • GlobeNewswire Inc. • 01/23/2026 09:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/13/2026 09:05:32 PM
